#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ventricular tachycardia Lennox-Gastaut syndrome Immunodeficiency congenital Neoplasm Adenoid cystic carcinoma Thrombotic microangiopathy Leiomyosarcoma Small intestine neuroendocrine tumour Immunoglobulin G4 related disease Neurodevelopmental disorder Laryngeal squamous cell carcinoma Non-small cell lung cancer Solitary fibrous tumour Extra-osseous Ewing's sarcoma recurrent Deafness bilateral More trials…

    Learn about Rare Diseases

    Anaplastic thyroid cancer – Treatment Nephroblastoma – Life with Disease Crigler-Najjar syndrome – Basic Information Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Focal segmental glomerulosclerosis – Diagnostics Primary hyperoxaluria – Diagnostics Mastocytosis – Treatment Nodal marginal zone B-cell lymphoma – Trials in Disease Cholangitis sclerosing – Life with Disease Angiosarcoma non-metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Afamelanotide Histidine Risedronate Sodium Topotecan Hydrochloride Domvanalimab Povidone Cefazolin Human Coagulation Factor Ix Df1001 Cabotegravir Sodium AMODIAQUINE Vortioxetine Latanoprost Balstilimab Zilovertamab Vedotin Omp10 Riboflavin Bp Gadobenate Dimeglumine C1 Esterase Inhibitor (Human) Haloperidol More therapies…

    Learn about Your Condition

    Aortic valve disease Lymphoma Intellectual disability Cervix carcinoma Muscle hypertrophy Factor IX deficiency Hypersomnia Vulval cancer recurrent Ichthyosis Hodgkin's disease Post-traumatic stress disorder Renal cancer stage IV Perinatal depression Behcet's syndrome Diabetic neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Safety and Tolerability of Lixudebart and Rituximab for Patients with Rapidly Progressive Glomerulonephritis Due to ANCA-Associated Vasculitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glomerulonephritis rapidly progressive
    Investigated Drugs:
    • Lixudebart
    • Rituximab
    Czechia Denmark France Germany Italy Spain +1

  • Study on TAK-330 for Reversing Anticoagulation in Patients on Factor Xa Inhibitors Needing Urgent Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Thrombosis prophylaxis
    Investigated Drugs:
    • Human Coagulation Factor Ii
    • Human Coagulation Factor Ix
    • Human Coagulation Factor Vii
    Austria Belgium Czechia France Germany Greece +5

  • Study on Atypical Teratoid/Rhabdoid Tumors in Children Using Dactinomycin, Carboplatin, and Cyclophosphamide

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atypical teratoid/rhabdoid tumour of CNS
    Investigated Drugs:
    • Dactinomycin
    • Ifosfamide
    • Methotrexate
    Belgium Czechia Denmark Finland France Germany +6

  • Study on the Safety and Effectiveness of VB10.16 and Pembrolizumab for Patients with HPV16-Positive Head and Neck Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Vb10.16
    • Pembrolizumab
    Czechia France Germany Hungary Norway Poland +1

  • Study on the Safety and Effect of EXOB-001 in Preventing Bronchopulmonary Dysplasia in Extremely Preterm Newborns

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    Investigated Drugs:
    • Allogeneic Umbilical Cord Mesenchymal Cells-Derived Extracellular Vesicles
    • Sodium Chloride
    Belgium Italy

  • Study on Sodium Phenylbutyrate for Improving Blood Sugar Control in Type 2 Diabetes Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Sodium Phenylbutyrate
    The Netherlands
Previous Page
1 … 594 595 596 597 598 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!